Ortona E, Riganò R, Margutti P, Notargiacomo S, Ioppolo S, Vaccari S, Barca S, Buttari B, Profumo E, Teggi A, Siracusano A
Laboratorio di Immunologia, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy.
Parasite Immunol. 2000 Nov;22(11):553-9. doi: 10.1046/j.1365-3024.2000.00336.x.
To evaluate the diagnostic sensitivity and specificity of immunoelectrophoresis (IEP), indirect haemagglutination (IHA), enzyme-linked immunosorbent assay (ELISA) and immunoblotting (IB), we compared their ability in detecting IgG antibodies to a hydatid fluid fraction (HFF) and to native and recombinant antigen B of Echinococcus granulosus. We tested sera from patients who had cystic echinococcosis (CE) grouped according to their type of cysts (n = 204), from patients with other parasitic diseases (n = 21), lung or liver carcinomas (n = 6) or serous cysts (n = 26) and from healthy controls (n = 90). HFF-IB gave the highest sensitivity (80%) followed by ELISA (72%), IHA (54%) and IEP (31%), respectively. The diagnostic sensitivity significantly (P < 0.01) decreased as cysts matured from type I-II to type VII. Recombinant and native antigen B-IB yielded similar sensitivity (74%). A large number of clinically or surgically confirmed CE patients (20%) resulted negative. In these patients' sera, IB to assess the usefulness of the recombinant E. granulosus elongation factor-1 beta/delta in detecting IgE antibodies yielded 33% of positivity. Our findings underline the need to standardize techniques and antigenic preparations and to improve the performance of immunodiagnosis by characterizing new antigens and detecting distinct immunoglobulin classes.
为评估免疫电泳(IEP)、间接血凝试验(IHA)、酶联免疫吸附测定(ELISA)和免疫印迹法(IB)的诊断敏感性和特异性,我们比较了它们检测抗细粒棘球绦虫囊液组分(HFF)以及天然和重组抗原B的IgG抗体的能力。我们检测了来自根据囊肿类型分组的囊性棘球蚴病(CE)患者(n = 204)、其他寄生虫病患者(n = 21)、肺癌或肝癌患者(n = 6)或浆液性囊肿患者(n = 26)以及健康对照者(n = 90)的血清。HFF-IB的敏感性最高(80%),其次分别是ELISA(72%)、IHA(54%)和IEP(31%)。随着囊肿从I-II型成熟到VII型,诊断敏感性显著降低(P < 0.01)。重组和天然抗原B-IB的敏感性相似(74%)。大量经临床或手术确诊的CE患者(20%)结果为阴性。在这些患者的血清中,用于评估重组细粒棘球绦虫延伸因子-1β/δ检测IgE抗体有效性的IB阳性率为33%。我们的研究结果强调了标准化技术和抗原制剂以及通过鉴定新抗原和检测不同免疫球蛋白类别来提高免疫诊断性能的必要性。